Back
Nuveen Select Tax Free Income Portfolio Vs. Akero Therapeutics Industry Stock Comparison
Sell
24
NXP
Nuveen Select Tax Free Income Portfolio
Last Price:
$14.02
Seasonality Move:
0.51%
Buy
64
AKRO
Akero Therapeutics
Last Price:
$54.26
Seasonality Move:
26.74%
Sell
24
Nuveen Select Tax Free Income Portfolio (NXP)
is a Sell
Is Nuveen Select Tax Free Income Portfolio a Buy, Sell or Hold?
-
The current Nuveen Select Tax Free Income Portfolio [NXP] share price is $13.98. The Score for NXP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
NXP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $53.94. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NXP Stock Price Chart
What is Nuveen Select Tax Free Income Portfolio's stock price today?
-
The Nuveen Select Tax Free Income Portfolio share price today is $13.98The current trend is relatively stagnant and NXP is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $53.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
NXP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 45.75 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.98 - 14.16) | Sell |
Bollinger Bands (100): | (13.97 - 14.77) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.89 | Buy |
Relative Strength Index (14 RSI): | 69.93 | Buy |
Chaikin Money Flow: | 736639 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.51 - 49.73) | Buy |
Bollinger Bands (100): | (34.52 - 51.16) | Buy |
NXP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14 | Sell |
20-day SMA: | 14.06 | Sell |
50-day SMA: | 14.02 | Sell |
200-day SMA: | 14.62 | Sell |
8-day EMA: | 14 | Sell |
20-day EMA: | 14.02 | Sell |
50-day EMA: | 14.1 | Sell |
200-day EMA: | 14.43 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.78 | Buy |
20-day SMA: | 45.41 | Buy |
50-day SMA: | 42.25 | Buy |
200-day SMA: | 35.92 | Buy |
8-day EMA: | 50.45 | Buy |
20-day EMA: | 47.08 | Buy |
50-day EMA: | 44.18 | Buy |
200-day EMA: | 37.59 | Buy |
Nuveen Select Tax Free Income Portfolio Earnings Growth & NXP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Nuveen Select Tax Free Income Portfolio Technical Analysis
May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |